Evidence map›Paper›PMID 31605309›Full record

ArticleInfection2019

Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins.

Atsushi Uda, Takeshi Kimura, Sho Nishimura, Kei Ebisawa, Goh Ohji, Mari Kusuki, Mariko Yahata, Rie Izuta, Tomoyuki Sakaue, Tatsuya Nakamura and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Risk Factors for the Acquisition ofAntibiotics (Basel, Switzerland) · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Atsushi UdaDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Takeshi KimuraDepartment of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Hyogo, Japan. kimutake@med.kobe-u.ac.jp.ORCID http://orcid.org/0000-0001-5254-3507
Sho NishimuraDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Kei EbisawaDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Goh OhjiDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Mari KusukiDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Mariko YahataDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Rie IzutaDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Tomoyuki SakaueDepartment of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Hyogo, Japan.
Tatsuya NakamuraDepartment of Medical Technology and Sciences, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, Japan.
Chihiro KoikeDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Issei TokimatsuDivision of Clinical Infectious Diseases, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan.
Ikuko YanoDepartment of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Hyogo, Japan.
Kentaro IwataDepartment of Infectious Disease, Kobe University Hospital, Kobe, Hyogo, Japan.
Takayuki MiyaraDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Kobe University Hospital · JPKyoto Tachibana University · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to evaluate the efficacy of an educational intervention on reducing the inappropriate use of oral third-generation cephalosporins, the prevalence of resistant bacteria, and clinical outcomes.

methodsA before-after study was conducted to compare the data for 1 year before and after intervention at a Japanese university hospital. Educational intervention included lectures for all medical staff on oral antibiotics and educational meetings with each medical department. The primary outcome was the use of oral third-generation cephalosporins in inpatients as measured by the monthly median days of therapy (DOTs) per 1000 patient days. Secondary outcomes included the use of each oral antibiotic in inpatients and outpatients, proportion of β-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae (BLNAR), penicillin-resistant Streptococcus pneumoniae (PRSP) and extended-spectrum β-lactamase producing Escherichia coli (ESBLEC), the incidence of hospital-acquired Clostridioides difficile infection (HA-CDI), and hospital mortality.

resultsThe use of oral third-generation cephalosporins in inpatients was significantly decreased after intervention [DOTs (interquartile range): 24.2 (23.5-25.1) vs. 3.7 (0.0-7.1), P < 0.001], and the value in outpatients was also decreased significantly. The use of fluoroquinolones and macrolides did not increase after intervention. The proportion of BLNAR, PRSP and ESBLEC did not change significantly during the study period. The incidence of HA-CDI was significantly decreased, and hospital mortality did not change after intervention.

conclusionEducational intervention was effective in reducing the use of oral third-generation cephalosporins without increasing the use of broad-spectrum antibiotics and worsening clinical outcome. The prevalence of resistant bacteria did not change during the study period.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsCephalosporinsHospitals, UniversityInappropriate PrescribingJapanAnti-Bacterial AgentsCephalosporinsAntibiotic stewardshipEducational interventionHaemophilus influenzaeOral third-generation cephalosporinsStreptococcus pneumoniae

Identifiers

PMID31605309
OpenAlexW2979870653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.